Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development-Reference-Cited by-同舟云学术

Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development

Published:2021-09-02 Issue:9 Volume:21 Page:983-991
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Dexter Emily¹,Kong Qingzhong¹²

Affiliation:

1. Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA

2. Department of Neurology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA

Funder

CJD Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1965882

Reference120 articles.

1. NMR structure of the mouse prion protein domain PrP(121–231)

2. NMR solution structure of the human prion protein

3. Immunohistochemical Expression of Prion Protein (PrPC) in the Human Forebrain During Development

4. Quantitative and qualitative analysis of cellular prion protein (PrPC) expression in bovine somatic tissues

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases;Acta Neuropathologica;2024-07-09

2. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases;2023-12-01

3. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein;Journal of Biological Chemistry;2023-02

4. Gene Therapy Strategies for Prophylactic and Therapeutic Treatments of Human Prion Diseases;Prions and Diseases;2023

5. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein;Cell and Tissue Research;2022-01-27